TMPRSS2 and prostate neoplasm: From a carefully characterized RNA pool of ERG expressing and TMPRSS2-ERG fusion harboring prostate tumors obtained from six radical prostatectomy specimens [29], cDNA molecules were generated and amplified using 5’ cap-specific forward primers and ERG-specific reverse primers.